PBH — Prestige Consumer Healthcare Share News
0.000.00%
- $2.19bn
- $4.25bn
- $1.09bn
Prestige Consumer Healthcare Q2 revenue beats on acquisition boost
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Prestige Consumer Healthcare beats Q1 revenue estimates, raises 2027 outlook
Brief: Prestige Consumer Healthcare Inc. Announces Offering Of $400 Million Senior Notes
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
Prestige Consumer Healthcare falls after weaker annual results
Prestige Consumer Healthcare Q4 revenue and adjusted EPS miss estimates
Deals of the day-Mergers and acquisitions
Prestige rises after $1.05 billion deal to buy Breathe Right
Deals of the day-Mergers and acquisitions
Prestige to buy Breathe Right brand in $1.05 billion deal (updated)
Prestige to buy Breathe Right brand in $1.05 billion deal
Prestige Consumer Q3 revenue slightly beats expectations
US FDA approves Vanda Pharmaceuticals' motion sickness drug (updated)
US FDA approves Vanda Pharmaceuticals' motion sickness drug
Prestige Consumer Heathcare beats Q2 revenue expectations, tightens FY forecast
Big Law rates for small firms? US appeals court takes up fee fight
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Prestige Consumer Healthcare On Aug 4, Unit Entered Agreement With Anjac Sas - SEC Filing